The Use of Flowable Resin Composite Stent in Reduction of Donor Site Morbidity After Free Gingival Graft Harvesting

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05779800
Collaborator
(none)
34
1
2
9.6
3.5

Study Details

Study Description

Brief Summary

After harvesting free gingival graft from the hard palate, Postoperative pain as well as bleeding are the most common complications.Different agents were used to protect the denuded areas on the palate as gelatin sponge, Hyaluronic acid gel and platelet rich fibrin (PRF) but still no gold standard material is present.

PICO format:

P: patients with mucogingival problems in need for free gingival graft or de-epithelialized connective tissue graft.I: Flowable resin composite stent. C: Periodontal pack. O: Post-operative pain T: day 3, 7, 14, 21 and 42 postoperative.

Aim of the study:

To compare the effect of flowable composite stent versus periodontal pack applied to palatal donor site after free gingival graft harvesting in terms of post-operative pain reduction.

Condition or Disease Intervention/Treatment Phase
  • Device: Flowble resin composite stent
  • Device: periodontal pack
N/A

Detailed Description

Intervention:

Flowable resin composite stent.

Procedure:

After the palatal sites be anaesthetized with 0.3 ml of a solution of 4% Articaine and 0.001% Adrenalin. Graft harvesting will be performed by basic surgical techniques described by Miller (1982). A rectangular shaped piece of mucosa will be harvested from the area of the hard palate by a split-thickness dissection.

The graft will then be used as it on the recipient bed. The graft dimensions will be recorded (width and length).

Denuded palatal area will then be protected using one of the following options:
  1. Periodontal pack (control group)

  2. flowble resin composite NEXOCOMP FLOW (intervention group)

Postoperative instructions:

Postoperative instructions will include discontinuing tooth brushing and flossing around the surgical sites until the day of periodontal dressing removal (day 7).

Patients will be directed to consume only soft foods during the first week and to avoid any mechanical trauma.

Patients will be scheduled to be seen on days 7, 14, 21 and 42 Periodontal pack and flowble resin composite stent will be first removed on day 7, and donor sites will be evaluated using selected parameters in both groups.

Thereafter, all patients will be followed up on days 14, 21 and 42 for further evaluation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Clinical Comparison of the Use of Flowable Resin Composite Stent Versus Periodontal Pack to Reduce Donor Site Morbidity After Free Gingival Graft Harvesting: A Randomized Clinical Trial
Actual Study Start Date :
Feb 15, 2023
Anticipated Primary Completion Date :
Nov 8, 2023
Anticipated Study Completion Date :
Dec 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Flowable resin composite stent group

Flowable resin composite is a bio compatible material used in dental field many years ago.

Device: Flowble resin composite stent
Flowble resin composite is a filling material used in operative dentistry and characterized by being flow and easily adapting the surfaces.
Other Names:
  • NEXOCOMP FLOW
  • Active Comparator: Periodontal pack group

    Non eugenol containing periodontal pack used in periodontal surgeries to protect the wound. Other name :COE_PAK

    Device: periodontal pack
    Non eugenol containing dressing supplied in two tubes
    Other Names:
  • COE-PAK
  • Outcome Measures

    Primary Outcome Measures

    1. Post operative pain [on day 7]

      Pain score reported by the patient directly through Visual Analogue Scale score (between 0 and 100. 0: no pain, 10: minimal pain, 50:moderate pain, 100: severe pain)

    Secondary Outcome Measures

    1. Color match [On day 42]

      The color of the palatal mucosa will be assessed by comparing it with that of the adjacent and opposite side by using the objective VAS (VAS score 0-10) represented by a continuous line, by a clinician blinded to the treatment group assignment.

    2. wound size [at day 21]

      To be recorded using (UNC 15) periodontal probe to the nearest measurement of 0.5 mm , length and width only

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 62 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with mucogingival defects scheduled for free gingival graft or de-epithelialized connective tissue graft.

    • Systemically healthy

    Exclusion Criteria:
    • Smokers

    • Occlusal trauma at site of graft

    • Pregnancy and lactation

    • Patients allergic to the used agents

    • Severe gagging reflex

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of dentistry, Cairo univesity Cairo Manial Egypt 11

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Elsayed Ahmed Hassan Temraz, demonstrator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05779800
    Other Study ID Numbers:
    • 9322
    First Posted:
    Mar 22, 2023
    Last Update Posted:
    Mar 22, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed Elsayed Ahmed Hassan Temraz, demonstrator, Cairo University

    Study Results

    No Results Posted as of Mar 22, 2023